Bpifrance

Activity from announced rounds

Activity in this selectionOct 17, 2026 · Jul 20, 2026

Bpifrance is France’s public investment bank, financing businesses through equity, loans and guarantees and supporting innovation and international expansion.

Its equity activity includes venture capital, growth investment and investments in other funds. Innovation financing can also support research, development and bringing a product to market, so founders may have financing options beyond a conventional equity round.

The appropriate route depends on the project and stage: research funding, a guarantee for borrowing, direct investment and export support serve different needs. Its bank-for-entrepreneurs model connects those instruments with programmes for developing a French business.

Sources
Rounds participated in
9
Confirmed lead rounds
0
1 roles undisclosed
New companies
9
First participation on record · 0 follow-on
Funding in participating rounds
$215.1M
9 disclosed · full round size, not this investor’s share

By stage

Seed2
Series A2
Series B2
Undisclosed2
Growth1

By primary sector

Biotech2
Fintech2
AI1
Cybersecurity1
Edtech1
2 more
Enterprise software1
Foodtech1

By country

France7
Belgium1
United Kingdom1

Rounds

9 in this selection
Spiko

Tokenized money-market infrastructure that gives businesses and investors access to cash yield.

$90MSeries B
Participant
Edison IA

Edison IA helps small and mid-sized businesses put AI to work through executive training, process diagnosis and deployed business agents.

€1MSeed
Participant
Hackuity

Hackuity consolidates vulnerability findings from security tools and helps organisations prioritise remediation against their actual exposure.

$19MFunding round
Participant
Delos

Delos sells autonomous AI workers that take on defined business tasks through a company’s messaging and software tools.

€10MSeries A
Participant
Kaiko

Market data, analytics and infrastructure that help financial institutions price, trade and manage risk in digital assets.

$57MSeries B-2 extension
Participant
Ed.ai

AI assessment software that helps teachers turn exam papers into editable grading rubrics, review assisted marking and target students’ learning gaps.

€5MSeed
Participant
One Biosciences

Single-cell tumour profiling for oncology teams and pharma and biotech partners, turning routine biopsy samples into clinical insights for treatment selection and drug development.

€3.3Mi-Démo 5 grant (France 2030)
Participant
MAASH

MAASH makes fermentation-derived mycoprotein ingredients for food manufacturers developing meat blends and alternative-protein products.

€12.2MEquity and public financing package
Participant
Brenus Pharma

Develops an off-the-shelf in vivo immunotherapy platform for solid tumors

€11MSeries A
Role not disclosed